Vault-13

APIMEDS PHARMACEUTICALS US I

COM SHS · CUSIP 03771D102

7 institutional holders +1 vs Q1 2026
426,282426.3k shares reported held*
$383.7kreported value*
2 new 1 added 2 reduced 1 sold out net sold ≈ $20.2k (-22.5k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.90.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

0510Q2 25: 7Q3 25: 8Q4 25: 7Q1 26: 6Q2 26: 77Q2 25Q3 25Q4 25Q1 26Q2 26
Numbers
QuarterHolders
Q2 20257
Q3 20258
Q4 20257
Q1 20266
Q2 20267

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q3 25: 7 bought or addedQ3 25: 4 cut or sold outQ3 25Q4 25: 6 bought or addedQ4 25: 4 cut or sold outQ4 25Q1 26: 3 bought or addedQ1 26: 3 cut or sold outQ1 26Q2 26: 3 bought or addedQ2 26: 3 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 202574
Q4 202564
Q1 202633
Q2 202633

Biggest buyers

JANE STREET GROUP, LLC New +15,993+16.0k
UBS Group AG Added +7,631+7.6k
Tower Research Capital LLC (TRC) New +1,664+1.7k

Biggest sellers

VANGUARD CAPITAL MANAGEMENT LLC Reduced -32,275-32.3k
TWO SIGMA SECURITIES, LLC Sold out -10,550-10.6k
GEODE CAPITAL MANAGEMENT, LLC Reduced -4,937-4.9k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Inscobee Inc. 13D · may seek influence no change · filed 2026-05-07
Stated purposeThe information set forth in Item 3 of the Schedule 13D is incorporated herein by reference. The Reporting Persons acquired the securities of the Issuer for investment purposes. As previously disclosed, the Reporting Persons engaged in discussions and disputes with the Issuer and certain other parties in connection with, among other things, the Merger Agreement, the Support & Lock-Up Agreement, the Voting Agreements and related transactions. On April 24, 2026, the Reporting Persons and certain other parties entered into a Settlement Agreement (the "Settlement Agreement"), as disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 4, 2026 (the "Current Report"), pursuant to which the parties agreed to resolve certain disputes relating… Full filing
34.3% no change 4.3m 2026-05-07
Ayrton Capital LLC 13G · institution new · filed 2026-02-11 10.0% new 1.4m 2026-02-11

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Hemenway Trust Co LLC 0.02% of their portfolio SALEM, NH 274,000274.0k $246.6k $246.6k 0.02% Unchanged
2 VANGUARD CAPITAL MANAGEMENT LLC 0.00% of their portfolio MALVERN, PA 63,65463.7k $57.3k $57.3k 0.00% Reduced -32.3k -32,275
3 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 35,11435.1k $31.6k $31.6k 0.00% Reduced -4.9k -4,937
4 VANGUARD FIDUCIARY TRUST CO 0.00% of their portfolio MALVERN, PA 24,03924.0k $21.6k $21.6k 0.00% Unchanged
5 JANE STREET GROUP, LLC 0.00% of their portfolio NEW YORK, NY 15,99316.0k $14.4k $14.4k 0.00% New
6 UBS Group AG 0.00% of their portfolio ZURICH, V8 11,81811.8k $10.6k $10.6k 0.00% Added +7.6k +7,631
7 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 1,6641.7k $1.5k $1.5k 0.00% New